Metronomic Chemotherapy in Triple-Negative Metastatic Breast Cancer: The Future Is Now?

Triple-negative breast cancer (TNBC) shows a very bad prognosis, even in early stages of disease. Metronomic chemotherapy refers to the minimum biologically effective dose of a chemotherapy agent given as a continuous dosing regimen with no prolonged drug-free breaks that leads to antitumor activity...

Descripción completa

Detalles Bibliográficos
Autores principales: Cazzaniga, M. E., Cortesi, L., Ferzi, A., Scaltriti, L., Cicchiello, F., Ciccarese, M., Torre, S. Della, Villa, F., Giordano, M., Verusio, C., Nicolini, M., Gambaro, A. R., Zanlorenzi, L., Biraghi, E., Casini, E., Legramandi, L., Rulli, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733132/
https://www.ncbi.nlm.nih.gov/pubmed/29333297
http://dx.doi.org/10.1155/2017/1683060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733132/
https://www.ncbi.nlm.nih.gov/pubmed/29333297
http://dx.doi.org/10.1155/2017/1683060

Ejemplares similares